Sclerosteosis
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
To further investigate the role of LRP4 in the bone formation process, we generated an Lrp4 mutated sclerosteosis mouse model by introducing the p.Arg1170Gln mutation in the mouse genome.
|
28477420 |
2017 |
Sclerosteosis
|
0.740 |
AlteredExpression
|
disease |
BEFREE |
In addition, to better understand the biology of LRP4, we investigated the circulating sclerostin levels in the serum of a patient suffering from sclerosteosis owing to a LRP4 mutation.
|
26751728 |
2016 |
Sclerosteosis
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Recently, two mutations in LRP4 gene underlying sclerosteosis were identified, reflecting the genetic heterogeneity of this disease.
|
24594238 |
2014 |
Sclerosteosis
|
0.740 |
GermlineCausalMutation
|
disease |
ORPHANET |
Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function.
|
21471202 |
2011 |
Sclerosteosis
|
0.740 |
Biomarker
|
disease |
MGD |
|
|
|
Sclerosteosis
|
0.740 |
Biomarker
|
disease |
CTD_human |
|
|
|
MYASTHENIC SYNDROME, CONGENITAL, 17
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia.
|
26052878 |
2015 |
MYASTHENIC SYNDROME, CONGENITAL, 17
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
|
24234652 |
2014 |
MYASTHENIC SYNDROME, CONGENITAL, 17
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Myasthenic Syndromes, Congenital
|
0.520 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia.
|
26052878 |
2015 |
Myasthenic Syndromes, Congenital
|
0.520 |
Biomarker
|
disease |
BEFREE |
By contrast, mutations in lipoprotein-like receptor 4 (LRP4), a long-time candidate gene for congenital myasthenia, and a novel phenotype of myasthenia with distal weakness and atrophy due to mutations in AGRN have now been described.
|
25305004 |
2014 |
Myasthenic Syndromes, Congenital
|
0.520 |
Biomarker
|
disease |
BEFREE |
We conclude that LRP4 is a new CMS disease gene and that the 3rd beta propeller domain of LRP4 mediates the two signaling pathways in a position-specific manner.
|
24234652 |
2014 |
Myasthenic Syndromes, Congenital
|
0.520 |
Biomarker
|
disease |
CTD_human |
|
|
|
Congenital Myasthenic Syndromes, Postsynaptic
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
|
24234652 |
2014 |
Congenital Myasthenic Syndromes, Postsynaptic
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Syndactyly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Our study broadens the pathogenic spectrum of LRP4 gene in syndactyly syndromes.
|
31750994 |
2020 |
Syndactyly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
This recessive mutation in LRP4 confirmed the diagnosis of CLS syndrome in two patients present with isolated hand syndactyly.
|
30041615 |
2018 |
Syndactyly
|
0.460 |
Biomarker
|
disease |
BEFREE |
In contrast, the syndactyly of SOST2 is particularly striking by involving bony fusion of some digits.
|
30077757 |
2018 |
Syndactyly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Variants in LRP4 have been previously associated with syndactyly in Cenani-Lenz syndactyly syndrome and Sclerosteosis 2, but have not been reported in individuals with isolated syndactyly.
|
29524275 |
2018 |
Syndactyly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
In contrast to the human sclerosteosis phenotype, we could not observe syndactyly in the forelimbs or hindlimbs of the Lrp4 KI animals.
|
28477420 |
2017 |
Syndactyly
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
These findings confirm that autosomal recessive loss-of-function mutations in Megf7/Lrp4 result in phenotypically similar forms of syndactyly in different mammalian species and that such mutations are the cause of MFD in bovines.
|
16963222 |
2006 |
Syndactyly
|
0.460 |
Biomarker
|
disease |
CTD_human |
Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice.
|
16207730 |
2005 |
Syndactyly
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Tooth Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice.
|
16207730 |
2005 |
Polysyndactyly
|
0.300 |
Biomarker
|
disease |
CTD_human |
Homozygous Megf7-deficient mice are growth-retarded, with fully penetrant polysyndactyly in their fore and hind limbs, and partially penetrant abnormalities of tooth development.
|
16207730 |
2005 |